Toxicity of Carboplatin-Niosomal Nanoparticles in a Brain Cancer Cell Line

Volume 24, Issue 11, November 2023, Pages 3985-3991

Mohadeseh Abbasi; Reza Reihanisaransari; Fatemeh Poustchi; Ali Hheidari; Parizad Ghanbarikondori; Hanifeh Salehi; Vahid Salehi; Mohaddeseh Izadkhah; Farimah Moazzam; Mohammadreza Allahyartorkaman

• View Article
• PDF 509.58 K

Association between Area under the Curve Estimated from Carboplatin Dose and Incidence of Severe Thrombocytopenia in Patients with Non-Hodgkin’s Lymphoma on DeVIC Therapy

Volume 24, Issue 6, June 2023, Pages 1963-1969

Kengo Umehara; Shinya Takada; Kaori Yama; Kayo Yamagishi; Ko Ebata; Toshiya Sakai; Michiya Kobayashi; Hideki Sato; Kozo Mino; Kastuya Fujimoto

• View Article
• PDF 388.27 K

A Phase IV Efficacy Study of Formeta Plus Carboplatin as First-Line Treatment of Advanced Non-Squamous, Non-Small Cell Lung Cancer in Iran: An Affordable Price with Clinical Benefit

Volume 19, Issue 10, October 2018, Pages 2973-2978

Adnan Khosravi; Babak Salimi; Zahra Esfahani-Monfared; Sharareh Seifi; Hanifeh Mirtavoos-Mahyari

• View Article
• PDF 501.53 K

Correlation of Expression Levels of Copper Transporter 1 and Thymidylate Synthase with Treatment Outcomes in Patients with Advanced Non-small Cell Lung Cancer Treated with S-1/Carboplatin Doublet Chemotherapy

Volume 19, Issue 2, February 2018, Pages 435-441

Maho Konishi; Asuka Imai; Masanori Fujii; Keisuke Sugimoto; Nobuyuki Katakami; Yukihiro Imai; Shingo Kamoshida

• View Article
• PDF 557.16 K

Ameliorative Effect of Coenzyme Q10 and/or Candesartan on Carboplatin-Induced Nephrotoxicity: Roles of Apoptosis, Transforming Growth Factor-Β1, Nuclear Factor Kappa-B And The Nrf2/HO-1 Pathway

Volume 18, Issue 6, June 2017, Pages 1629-1636

Ahmed M Kabel; Abeer A Elkhoely

• View Article
• PDF 1.03 M

Comparison of Hypersensitivity Reactions to Carboplatin Retreatment in Gynecologic Cancer Patients between One and Two Hour Infusions: a Randomized Trial Study

Volume 18, Issue 2, February 2017, Pages 425-430

Weerawich Pornwattanakrilert; Prapaporn Suprasert

• View Article
• PDF 304.83 K

General Characteristics and Cytotoxic Effects of Nano-Poly (Butyl Cyanoacrylate) Containing Carboplatin on Ovarian Cancer Cells

Volume 18, Issue 1, January 2017, Pages 87-91

Leila Kanaani; Meysam Ebrahimi-Far; S Maryam Kazemi; Edris Choupani; Maral Mazloumi Tabrizi; hasan ebrahimi shahmabadi; Azim Akbarzadeh Khiyavi

• View Article
• PDF 303.88 K

Replacing Actinomycin-D with Carboplatin for Newly Diagnosed Rhabdomyosarcoma

Volume 16, Issue 8, August 2015, Pages 3351-3354

• View Article
• PDF 649.65 K

Clinical Investigation of Efficacy of Albumin Bound Paclitaxel plus Platinum Compounds as First-line Chemotherapy for Stage Ⅲ/IV Squamous Non-small Cell Lung Cancer

Volume 15, Issue 17, December 2014, Pages 7453-7457

• View Article
• PDF 632.44 K

Role of Concomitant Chemoradiation in Locally Advanced Head and Neck Cancers

Volume 15, Issue 10, October 2014, Pages 4147-4152

• View Article
• PDF 681.32 K

GSTT1 null and MPO -463G>A Polymorphisms and Carboplatin Toxicity in an Indian Population

Volume 14, Issue 8, August 2013, Pages 4739-4742

• View Article
• PDF 339.59 K

Carboplatin and Doxorubicin in Treatment of PediatricOsteosarcoma: A 9-year Single Institute Experience in theNorthern Region of Thailand

Volume 14, Issue 2, February 2013, Pages 1101-1106

• View Article
• PDF 590.13 K

Induction of Apoptosis by a Combination of Paclitaxel and Carboplatin in the Presence of Hyperthermia

Volume 13, Issue 1, January 2012, Pages 81-85

• View Article
• PDF 613.43 K

Vinorelbine in Combination with Carboplatin followed by Single-agent Consolidation Therapy for Unresectable Localized or Metastatic Non-small-cell Lung Carcinomas

Volume 10, Issue 6, June 2009, Pages 1051-1055

• View Article
• PDF 35.86 K